N. Park

H. Shin, H. Cheong, Y. Kim, 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Pallidal Signal Intensities on T1-weighted MRI are Highly Observed in Advanced Liver Cirrhosis

Yangho Kim, N. Park, Y. Weon, 2012 .

High Pallidal T1 Signal is Rarely Observed in Obstructive Jaundice, but is Frequently Observed in Liver Cirrhosis

Yangho Kim, N. Park, Sung-Jo Bang, 2007, Journal of occupational health.

Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States Tong MJ, Hsien C, Hsu L, Sun HE, Blatt LM

N. Park, 2009 .

A gastrointestinal stromal tumor of the duodenum masquerading as a pancreatic head tumor.

H. Cha, N. Park, I. Jeong, 2007, World journal of gastroenterology.

Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.

Byung Gyu Kim, H. Lee, Hong-Kyu Kim, 2017, Journal of hepatology.

Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection.

D. J. Kim, S. Yoon, Y. Cho, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Korean Genome Project: 1094 Korean personal genomes with clinical information.

Yun Sung Cho, G. Church, A. Manica, 2020, Science advances.

Somatic Mutation of ARHI Gene in Hepatocellular Carcinomas

N. Park, S. Jung, J. Shin, 2015, Pathology & Oncology Research.

The presence of high level soluble herpes virus entry mediator in sera of gastric cancer patients

Y. Min, W. An, N. Park, 2011, Experimental & Molecular Medicine.

Localized Uterine Recurrence of Hepatocellular Carcinoma 4 Years after Curative Resection

N. Park, J. Shin, Y. Nah, 2012 .

Mutational analysis of SATB1 gene in hepatocellular carcinomas

N. Park, S. Jung, J. Shin, 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Antifibrogenic effects of tamoxifen in a rat model of periportal hepatic fibrosis

H. Lee, Y. Chung, N. Park, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients

June-Sung Lee, Y. Cho, Jeong‐Hoon Lee, 2022, Drug design, development and therapy.

Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth

J. Sin, N. Park, H. Cho, 2016, The Journal of Immunology.

Tenofovir‐based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir

Eun Hye Kim, Byung Gyu Kim, N. Park, 2015, Journal of gastroenterology and hepatology.

Prediction of response to entecavir therapy in patients with HBeAg‐positive chronic hepatitis B based on on‐treatment HBsAg, HBeAg and HBV DNA levels

B. Kim, N. Park, I. Jeong, 2012, Journal of viral hepatitis.

Response to Adefovir Depends on Mutation Patterns in Precore Region, Basal Core Promoter and Reverse Transcriptase, and On-Treatment Responses in Lamivudine-Resistant Chronic Hepatitis B Patients

N. Park, J. Shin, E. Choi, 2010, Intervirology.

Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK–NF-κB signaling pathway

I. Han, N. Park, Gong-Rak Lee, 2014, Clinical & Experimental Metastasis.

DRG2 Regulates G2/M Progression via the Cyclin B1-Cdk1 Complex

Jeong Woo Park, I. Han, N. Park, 2016, Molecules and cells.

[Clinical Application of Non-invasive Diagnostic Tests for Liver Fibrosis].

N. Park, J. Shin, J. Shin, 2016, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

MONW Phenotype Is Associated With Advanced Colorectal Adenoma in Korean Men

C. Yoo, N. Park, S. Jung, 2012, Obesity.

Capsaicin Induces Apoptosis of Cisplatin-Resistant Stomach Cancer Cells by Causing Degradation of Cisplatin-Inducible Aurora-A Protein

I. Han, Sun-Young Lee, N. Park, 2011, Nutrition and cancer.

Metastasis of hepatocellular carcinoma to the small bowel manifested by intussusception.

H. Cha, N. Park, I. Jeong, 2006, World journal of gastroenterology.

Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti‐HBs

J. Lee, Y. Cho, N. Park, 2013, Journal of medical virology.

Clinical Course of Partial Virologic Response with Prolonged Tenofovir Therapy in Nuclos(t)ides-Naïve Patients with Chronic Hepatitis B

Byung Gyu Kim, N. Park, S. Jung, 2017, Digestive Diseases and Sciences.

Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir

N. Park, S. Jung, J. Shin, 2017, Clinical and molecular hepatology.

Efficacy of Tenofovir-based Rescue Therapy in Lamivudine-resistant Chronic Hepatitis B Patients With Failure of Lamivudine and Adefovir Combination.

Byung Gyu Kim, N. Park, I. Jeong, 2015, Clinical therapeutics.

Treatment of chronic hepatitis B

N. Park, J. Shin, J. Shin, 2009 .

Title Page Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: a propensity score-matched analysis

N. Park, S. Jung, J. Shin, 2021 .

Association of VARS2‐SFTA2 polymorphisms with the risk of chronic hepatitis B in a Korean population

H. Shin, H. Cheong, Jung-Hwan Yoon, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Chronic hepatitis B in hepatocarcinogenesis

N. Park, I. Song, Y.-H. Chung, 2006, Postgraduate Medical Journal.

Clinical significance of hepatitis B e antigen level measurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive.

N. Park, I. Jeong, S. Jung, 2006, World journal of gastroenterology.

Efficacy of lamivudine re‐treatment for relapsed patients after an initial lamivudine therapy in HBeAg‐positive chronic hepatitis B

N. Park, K. Joo, I. Jeong, 2005, Journal of viral hepatitis.

Monitoring of HBeAg levels may help to predict the outcomes of lamivudine therapy for HBeAg positive chronic hepatitis B

N. Park, J. Shin, K. Joo, 2005, Journal of viral hepatitis.

Tumor Necrosis Factor-Alpha Gene Polymorphism Associated With Development of Hepatitis B Virus–associated Hepatocellular Carcinoma

E. Shin, Y. Chung, N. Park, 2015, Journal of clinical gastroenterology.

Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma

Sharon I. Greenblum, Jinghui Zhang, K. Buetow, 2010, Hepatology.

Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy

H. Lee, Y. Chung, N. Park, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Combination of α‐interferon with lamivudine reduces viral breakthrough during long‐term therapy

H. Lee, Y. Chung, N. Park, 2004 .

Clinical usefulness of sequential hepatitis B virus DNA measurement (the roadmap concept) during adefovir treatment in lamivudine-resistant patients

N. Park, I. Jeong, S. Jung, 2009, Antiviral therapy.

[Efficacy of lamivudine in patients with hepatitis B e antigen-negative chronic liver diseases].

N. Park, K. Joo, I. Jeong, 2003, Taehan Kan Hakhoe chi = The Korean journal of hepatology.

HBV Dna Level at 24 Weeks is the Best Predictor of Virological Response to Adefovir Add-On Therapy in Patients with Lamivudine Resistance

Byung Gyu Kim, N. Park, I. Jeong, 2012, Antiviral therapy.

The Level of HBV DNA at Month 12 Is an Important Predictor of Virological Breakthrough During Adefovir Monotherapy in Chronic Hepatitis B Patients with Lamivudine Resistance

N. Park, S. Jung, M. Kim, 2011, Digestive Diseases and Sciences.

[503] OVERLAPPING OF LAMIVUDINE AND ADEFOVIR BEFORE SWITCHING TO ADEFOVIR MONOTHERAPY IN LAMIVUDINE RESISTANT CHRONIC HEPATITIS B: IS IT NECESSARY?

S. Bae, K. Koh, S. Paik, 2007 .

[A case of fulminant hepatic failure secondary to hepatic metastasis of small cell lung carcinoma].

J. Lee, N. Park, J. Eum, 2007, The Korean journal of hepatology.

Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: possible implications on survival.

E. Shin, Y. Chung, N. Park, 2012, Journal of hepatology.

Combination of alpha-interferon with lamivudine reduces viral breakthrough during long-term therapy.

H. Lee, Y. Chung, N. Park, 2004, Journal of gastroenterology and hepatology.

Clinical Characteristics of Occult HBV Infection and Impact on Treatment Response in Patients with Chronic Hepatitis C

J. Hong, N. Park, B. R. Park, 2012 .

[Predictive factors and efficacy of lamivudine treatment in chronic hepatitis B infection].

N. Park, K. Joo, Sung-Jo Bang, 2003, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir

S. Lee, N. Park, I. Jeong, 2020, Clinical and molecular hepatology.

The risk of hepatocellular carcinoma within and beyond the first 5 years of entecavir in Korean patients with chronic hepatitis B

Byung Gyu Kim, S. Lee, N. Park, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Mortality, liver transplantation and hepatic complications in patients with treatment‐naïve chronic hepatitis B treated with entecavir vs tenofovir

Byung Gyu Kim, S. Lee, N. Park, 2018, Journal of viral hepatitis.

Identification of additional EHMT2 variant associated with the risk of chronic hepatitis B by GWAS follow-up study

H. Shin, H. Cheong, Y. Kim, 2017, Genes & Immunity.

Relationship of Biological Indices of Manganese with Pallidal Index on MRI in Liver Cirrhotics.

C. Yoo, Hun Lee, Yangho Kim, 2004 .

Clinical course of patients with insufficient viral suppression during entecavir therapy in genotype C chronic hepatitis B.

Byung Gyu Kim, N. Park, I. Jeong, 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Performance Evaluation of 3 Kinds of HBsAg Qualitative Assays and 2 Kinds of Quantitative Assays

N. Park, Y. Cha, Jae-Sun Park, 2013 .

Performance Evaluation of Immunoassay Detection of HBsAg Mutants and Their Clinical Significance in the High Risk Groups

N. Park, Y. Cha, Jae-Sun Park, 2013 .

The virological response in Koreans infected with HCV genotype 1 did not differ between groups treated with a full dose or reduced dose (≥80 % full dose) of peginterferon alfa-2a: a prospective randomized multicenter trial

June-Sung Lee, D. J. Kim, J. Jang, 2013, Hepatology International.

Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir

S. Lee, N. Park, S. Jung, 2020, Digestive Diseases and Sciences.

Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.

Y. Chung, N. Park, I. Song, 2007, Gut and liver.

[Molecular mechanisms of hepatitis B virus-associated hepatocellular carcinoma].

Y. Chung, N. Park, 2007, The Korean journal of hepatology.

Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B

E. Shin, Y. Chung, N. Park, 2014, Hepatology.

A Case of Colonic Duplication Cyst Mimicking Gastrointestinal Stromal Tumor

N. Park, I. Jeong, S. Jung, 2009 .

A Case of Simultaneous Xanthogranulomatous Cholecystitis and Carcinoma of the Gallbladder

N. Park, K. Joo, Do Ha Kim, 2003, The Korean journal of internal medicine.

Depletion of Aurora A leads to upregulation of FoxO1 to induce cell cycle arrest in hepatocellular carcinoma cells

H. Cha, I. Han, Sun-Young Lee, 2013, Cell cycle.

Genetic predisposition of hand‐foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma

E. Shin, H. Lee, S. Bae, 2013, Cancer.

Successful outcomes of endoscopic resection for gastric adenomas and early cancers located on the pyloric ring (with video).

N. Park, I. Jeong, S. Jung, 2010, Gastrointestinal endoscopy.

Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis

H. Lee, J. Cheon, N. Park, 2020, Liver Cancer.

Korean Genome Project: 1094 Korean personal genomes with clinical information

Yun Sung Cho, G. Church, A. Manica, 2020, Science Advances.

Hepatic miR-20b promotes nonalcoholic fatty liver disease by suppressing PPARα

Hongtae Kim, J. Choi, H. Jang, 2021, bioRxiv.

Relationship between polymorphisms near the IL28B gene and spontaneous HBsAg seroclearance: a systematic review and meta‐analysis

N. Park, J. Yoon, M. Lee, 2014, Journal of viral hepatitis.

Tonicity-responsive enhancer-binding protein promotes hepatocellular carcinogenesis, recurrence and metastasis

K. Myung, Jiyoung Park, N. Park, 2018, Gut.

Reply: To PMID 23907815.

E. Shin, Y. Chung, N. Park, 2014, Hepatology.

Whole Blood and Red Blood Cell Manganese Reflected Signal Intensities of T1‐Weighted Magnetic Resonance Images better than Plasma Manganese in Liver Cirrhotics

Hun Lee, C. Yoo, Jungsun Park, 2005, Journal of occupational health.

Mutational analysis of FEN1 Gene in hepatocellular carcinomas

H. Cha, N. Park, S. Jung, 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Fixed Dose Rate Infusion of Gemcitabine with Oral Doxifluridine and Leucovorin for Advanced Unresectable Pancreatic Cancer: A Phase II Study

Su-Jin Shin, Y. Min, N. Park, 2007, Chemotherapy.

Characteristic clinical features of hepatocellular carcinoma associated with Budd–Chiari syndrome: evidence of different carcinogenic process from hepatitis B virus-associated hepatocellular carcinoma

H. Lee, Y. Chung, N. Park, 2004, European journal of gastroenterology & hepatology.

A genome-wide association study identified new variants associated with the risk of chronic hepatitis B.

H. Shin, H. Cheong, Y. Kim, 2013, Human molecular genetics.

Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control Study

Hwa Young Choi, D. J. Kim, G. Gwak, 2018, Journal of Korean medical science.

Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: A propensity score-matched analysis

N. Park, S. Jung, Joonho Jeong, 2021, Clinical and molecular hepatology.

Identification of novel OCT4 genetic variant associated with the risk of chronic hepatitis B in a Korean population

H. Shin, H. Cheong, B. Ju, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Welfare Genome Project: A Participatory Korean Personal Genome Project With Free Health Check-Up and Genetic Report Followed by Counseling

Yun Sung Cho, A. Manica, J. Edwards, 2021, Frontiers in Genetics.

Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir-vs. entecavir-based regimens: individual patient data meta-analysis.

W. Kim, C.-H. Chen, N. Park, 2022, Journal of hepatology.

Fragile histidine triad gene alterations are not essential for hepatocellular carcinoma development in South Korea.

N. Park, C. Nam, J. Shin, 2008, World journal of gastroenterology.

Combined Cis-platinum and Alpha Interferon Therapy of Advanced Hepatocellular Carcinoma

N. Park, B. Han, Sang Uk Lee, 1996, The Korean journal of internal medicine.

Identification of additional EHMT2 variant associated with the risk of chronic hepatitis B by GWAS follow-up study

H. Shin, H. Cheong, Y. Kim, 2017, Genes & Immunity.

Liver Resection Versus Transplantation for Hepatocellular Carcinoma within Milan Criteria: An Intention-to-treat Analysis

N. Park, C. Nam, Y. Nah, 2010 .

Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir

S. Lee, N. Park, S. Jung, 2018, The American Journal of Gastroenterology.

Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK–NF-κB signaling pathway

I. Han, N. Park, Soo Hwa Jang, 2014, Clinical & Experimental Metastasis.

Overexpression of bone morphogenetic protein 4 in STO fibroblast feeder cells represses the proliferation of mouse embryonic stem cells in vitro

I. Han, N. Park, Guenhwi Kim, 2012, Experimental & Molecular Medicine.

Metabolic syndrome is associated with increased risk of recurrent colorectal adenomas in Korean men

C. Yoo, Choung-Soo Kim, N. Park, 2012, International Journal of Obesity.

261 VASCULAR ENDOTHELIAL GROWTH FACTOR AS A PREDICTOR OF RESPONSE TO THE COMBINED THERAPY WITH SORAFENIB AND TRANSARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

E. Shin, H. Lee, S. Ryu, 2013 .

Roads towards a new tailored therapy for hepatocellular carcinoma: diagnostic, therapeutic and prognostic implications of microRNAs

Y. Chung, N. Park, C. J. Kim, 2012, Liver international : official journal of the International Association for the Study of the Liver.

Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study

J. Jang, S. Paik, Y. Kim, 2023, The Korean journal of internal medicine.

Thrap3 promotes nonalcoholic fatty liver disease by suppressing AMPK-mediated autophagy.

Hongtae Kim, D. Ryu, J. Choi, 2023, Experimental & molecular medicine.

A Case of Chronic Pancreatitis Associated with Liver Infarction and Acrodermatitis Enteropathica

N. Park, K. Joo, Do Ha Kim, 2002, The Korean Journal of Internal Medicine.

Experimental model of hepatic fibrosis following repeated periportal necrosis induced by allylalcohol.

S. H. Yang, N. Park, I. Song, 2000, Scandinavian journal of gastroenterology.

[Clinical Application of Non-invasive Diagnostic Tests for Liver Fibrosis].

N. Park, J. Shin, 2016, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

HBV Dna Level at 24 Weeks is the Best Predictor of Virological Response to Adefovir Add-On Therapy in Patients with Lamivudine Resistance

Byung Gyu Kim, N. Park, I. Jeong, 2012, Antiviral therapy.

The risk of hepatocellular carcinoma within and beyond the first 5 years of entecavir in Korean patients with chronic hepatitis B

Byung Gyu Kim, S. Lee, N. Park, 2018, Liver international : official journal of the International Association for the Study of the Liver.